Rajkumar Verma1,2, Rodney M Ritzel1, Nia M Harris1, Juneyoung Lee3, TaeHee Kim4, Gopal Pandi4, Raghu Vemuganti4, Louise D McCullough5,3. 1. From the Department of Neuroscience, UConn Health, Farmington, CT (R.V., R.M.R., N.M.H., L.D.M.). 2. Research Division, William S. Middleton Veterans Administration Hospital, Madison, WI (R.V.). 3. Department of Neurology, McGovern Medical School University of Texas Health Science Center, Houston (J.L., L.D.M.). 4. Department of Neurological Surgery, University of Wisconsin, Madison (T.K., G.P., R.V.). 5. From the Department of Neuroscience, UConn Health, Farmington, CT (R.V., R.M.R., N.M.H., L.D.M.) Louise.D.McCullough@uth.tmc.edu.
Abstract
BACKGROUND AND PURPOSE: Social isolation increases mortality and impairs recovery after stroke in clinical populations. These detrimental effects have been recapitulated in animal models, although the exact mechanism mediating these effects remains unclear. Dysregulation of microRNAs (miRNAs) occurs in both strokes as well as after social isolation, which trigger changes in many downstream genes. We hypothesized that miRNA regulation is involved in the detrimental effects of poststroke social isolation in aged animals. METHODS: We pair-housed 18-month-old C57BL/6 male mice for 2 weeks before a 60-minute right middle cerebral artery occlusion or sham surgery and then randomly assigned mice to isolation or continued pair housing immediately after surgery. We euthanized mice either at 3, 7, or 15 days after surgery and isolated the perilesional frontal cortex for whole microRNAome analysis. In an additional cohort, we treated mice 1 day after stroke onset with an in vivo-ready antagomiR-141 for 3 days. RESULTS: Using whole microRNAome analysis of 752 miRNAs, we identified miR-141-3p as a unique miRNA that was significantly upregulated in isolated mice in a time-dependent manner up to 2 weeks after stroke. Posttreatment with an antagomiR-141-3p reduced the postisolation-induced increase in miR-141-3p to levels almost equal to those of pair-housed stroke controls. This treatment significantly reduced mortality (by 21%) and normalized infarct volume and neurological scores in poststroke-isolated mice. Quantitative PCR analysis revealed a significant upregulation of Tgfβr1 (transforming growth factor beta receptor 1, a direct target of miR-141-3p) and Igf-1 (insulin-like growth factor 1) mRNA after treatment with antagomiR. Treatment also increased the expression of other pleiotropic cytokines such as Il-6 (interleukin 6) and Tnf-α (tumor necrosis factor-α), an indirect or secondary target) in brain tissue. CONCLUSIONS: miR-141-3p is increased with poststroke isolation. Inhibition of miR-141-3p improved mortality, neurological deficits, and decreased infarct volumes. Importantly, these therapeutic effects occurred in aged animals, the population most at risk for stroke and poststroke isolation.
BACKGROUND AND PURPOSE: Social isolation increases mortality and impairs recovery after stroke in clinical populations. These detrimental effects have been recapitulated in animal models, although the exact mechanism mediating these effects remains unclear. Dysregulation of microRNAs (miRNAs) occurs in both strokes as well as after social isolation, which trigger changes in many downstream genes. We hypothesized that miRNA regulation is involved in the detrimental effects of poststroke social isolation in aged animals. METHODS: We pair-housed 18-month-old C57BL/6 male mice for 2 weeks before a 60-minute right middle cerebral artery occlusion or sham surgery and then randomly assigned mice to isolation or continued pair housing immediately after surgery. We euthanized mice either at 3, 7, or 15 days after surgery and isolated the perilesional frontal cortex for whole microRNAome analysis. In an additional cohort, we treated mice 1 day after stroke onset with an in vivo-ready antagomiR-141 for 3 days. RESULTS: Using whole microRNAome analysis of 752 miRNAs, we identified miR-141-3p as a unique miRNA that was significantly upregulated in isolated mice in a time-dependent manner up to 2 weeks after stroke. Posttreatment with an antagomiR-141-3p reduced the postisolation-induced increase in miR-141-3p to levels almost equal to those of pair-housed stroke controls. This treatment significantly reduced mortality (by 21%) and normalized infarct volume and neurological scores in poststroke-isolated mice. Quantitative PCR analysis revealed a significant upregulation of Tgfβr1 (transforming growth factor beta receptor 1, a direct target of miR-141-3p) and Igf-1 (insulin-like growth factor 1) mRNA after treatment with antagomiR. Treatment also increased the expression of other pleiotropic cytokines such as Il-6 (interleukin 6) and Tnf-α (tumor necrosis factor-α), an indirect or secondary target) in brain tissue. CONCLUSIONS:miR-141-3p is increased with poststroke isolation. Inhibition of miR-141-3p improved mortality, neurological deficits, and decreased infarct volumes. Importantly, these therapeutic effects occurred in aged animals, the population most at risk for stroke and poststroke isolation.
Authors: Kimberly M Henderson; Cari J Clark; Tené T Lewis; Neelum T Aggarwal; Todd Beck; Hongfei Guo; Scott Lunos; Ann Brearley; Carlos F Mendes de Leon; Denis A Evans; Susan A Everson-Rose Journal: Stroke Date: 2012-12-13 Impact factor: 7.914
Authors: Kate Karelina; Greg J Norman; Ning Zhang; John S Morris; Haiyan Peng; A Courtney DeVries Journal: Proc Natl Acad Sci U S A Date: 2009-03-23 Impact factor: 11.205
Authors: Rodney M Ritzel; Anita R Patel; Jeremy M Grenier; Joshua Crapser; Rajkumar Verma; Evan R Jellison; Louise D McCullough Journal: J Neuroinflammation Date: 2015-05-29 Impact factor: 8.322
Authors: Mary S Lopez; Kahlilia C Morris-Blanco; Nancy Ly; Carly Maves; Robert J Dempsey; Raghu Vemuganti Journal: Transl Stroke Res Date: 2021-11-18 Impact factor: 6.829
Authors: Janelle M Korf; Pedram Honarpisheh; Eric C Mohan; Anik Banerjee; Maria P Blasco-Conesa; Parisa Honarpisheh; Gary U Guzman; Romeesa Khan; Bhanu P Ganesh; Amy L Hazen; Juneyoung Lee; Aditya Kumar; Louise D McCullough; Anjali Chauhan Journal: J Immunol Date: 2022-06-22 Impact factor: 5.426
Authors: Debora Kamin Mukaz; Neil A Zakai; Salvador Cruz-Flores; Louise D McCullough; Mary Cushman Journal: Stroke Date: 2020-10-26 Impact factor: 7.914
Authors: John Brown; You Jeong Park; Jea-Young Lee; Thomas N Chase; Minako Koga; Cesar V Borlongan Journal: Int J Mol Sci Date: 2020-04-19 Impact factor: 5.923